Physiomics (GB:PYC) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Physiomics plc has appointed Dr. Mark Davies as Head of Quantitative Pharmacology and Data Science, aiming to enhance their Modelling, Simulation and Data Science services. With over 20 years of experience in drug development and data informatics, Dr. Davies is expected to drive growth and operational excellence, expanding the company’s market reach and service offerings. This strategic move is set to strengthen Physiomics’ position in the pharmaceutical and healthtech sectors.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.
